Nigeria Infectious Disease Therapeutics Market Analysis

Nigeria Infectious Disease Therapeutics Market Analysis


$ 3999

By 2030, it is anticipated that the Nigeria infectious disease therapeutics market will reach a value of $163.7 Mn from $107.9 Mn in 2022, growing at a CAGR of 5.4% during 2022-2030. The Infectious Disease Therapeutics in Nigeria is dominated by a few domestic pharmaceutical companies such as Fidson Healthcare, Emzor Pharmaceutical and Afrigen Biologics. The Infectious Disease Therapeutics market in Nigeria is segmented into different therapeutic areas and different diseases type. The major factors affecting the Nigeria infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, COVID-19, and the amount of healthcare funding for infectious diseases treatment in various areas of Nigeria.

ID: IN10NGPH038 CATEGORY: Pharmaceuticals GEOGRAPHY: Nigeria AUTHOR: Dr. Vishwa Modhia

Buy Now

Nigeria Infectious Disease Therapeutics Analysis Summary

By 2030, it is anticipated that the Nigeria infectious disease therapeutics market will reach a value of $163.7 Mn from $107.9 Mn in 2022, growing at a CAGR of 5.4% during 2022-2030.

Nigeria is a lower middle-income, developing country located in West Africa with a coast on the Gulf of Guinea and the Atlantic Ocean. According to the World Factbook, Nigeria is particularly vulnerable to the infectious diseases listed below. Food or waterborne infections include bacterial and protozoal diarrhoea, hepatitis A, and typhoid fever. Water-borne infectious diseases such as leptospirosis and schistosomiasis are common in Nigeria. Rabies, malaria, dengue fever, yellow fever, meningococcal meningitis, and Lassa fever are Nigeria's other main infectious diseases.

Nigeria is also involved in vaccine development, with the National Primary Health Care Development Agency in charge of vaccine development and delivery. The agency manufactures a variety of vaccines, including those against polio, measles, and yellow fever. Nigeria's government spends 3.4% of its GDP on healthcare.

Nigeria Infectious Disease Therapeutics Market Analysis

Market Dynamics

Market Growth Drivers Analysis

The President's Malaria Initiative (PMI), led by USAID and the CDC, collaborates with other organisations to assist over 41 Mn Nigerians. Despite the challenges created by COVID-19 in 2020, the PMI was able to assist Nigeria in distributing 14.7 Mn malaria treatment tablets, 8.2 Mn of which went to pregnant women and children. These aspects could boost Nigeria's infectious disease therapeutics market.

Market Restraints

The creation of novel pharmaceuticals and treatments necessitates substantial investment, and finance can be a barrier for many research efforts. Due to fiscal restrictions or conflicting objectives, funding for research and development in Nigeria may be constrained. Developing new pharmaceuticals and treatments necessitates adherence to regulatory rules established by agencies such as Nigeria's National Agency for Food and Drug Administration and Control (NAFDAC). Manufacturing activity accounts for only 10% of Nigeria's GDP, despite the Made in Nigeria (MINE) project's goal of increasing it to 20%. These factors may deter new entrants into the Nigeria infectious disease therapeutics market.

Competitive Landscape

Key Players

  • National Institute for Pharmaceutical Research and Development (NIPRD) - NIPRD is a research institution in Nigeria that is involved in the development of drugs, vaccines, and herbal medicines for a range of diseases
  • Emzor Pharmaceutical Industries Limited - Emzor is a Nigerian pharmaceutical company that produces a range of medicines, including treatments for infectious diseases such as malaria, typhoid fever, and respiratory infections
  • Fidson Healthcare Plc - Fidson Healthcare is a Nigerian pharmaceutical company that produces a range of medicines, including treatments for infectious diseases such as malaria, typhoid fever, and respiratory infections
  • Afrigen Biologics Nigeria Limited - Afrigen Biologics Nigeria is a Nigerian biotechnology company that develops and produces biopharmaceuticals for infectious diseases such as HIV/AIDS and tuberculosis

Healthcare Policies and Reimbursement Scenarios

The National Agency for Food and Drug Administration and Control regulates infectious disease therapies in Nigeria (NAFDAC). The NAFDAC oversees assessing the safety, efficacy, and quality of all medications and medical equipment, including those used to treat infectious diseases. The National Health Insurance Scheme (NHIS) oversees the national health insurance programme, which covers a variety of healthcare services, including pharmaceuticals and infectious disease treatments.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Infectious Disease Therapeutics Segmentation

By Mode of Treatment (Revenue, USD Billion):

  • Vaccines
  • Drugs

By Applications (Revenue, USD Billion):

  • HIV/AIDS
  • Influenza
  • Hepatitis
  • Malaria
  • Tuberculosis
  • Others

By Disease Type (Revenue, USD Billion):

  • Viral Diseases
  • Bacterial Diseases
  • Fungal Diseases
  • Parasitic Diseases
  • Others

By Target Organism (Revenue, USD Billion):

  • Antibiotics
  • Antivirals
  • Antifungals
  • Anti-Parasitic
  • Others

By End User (Revenue, USD Billion):

  • Hospitals and Clinics
  • Ambulatory Care Centers
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.

By 2030, it is anticipated that the Nigeria infectious disease therapeutics market will reach a value of $163.7 Mn from $107.9 Mn in 2022, growing at a CAGR of 5.4% during 2022-2030.

In Nigeria, the regulation of infectious disease therapeutics is overseen by the National Agency for Food and Drug Administration and Control (NAFDAC).

The Infectious Disease Therapeutics in Nigeria is dominated by a few domestic pharmaceutical companies such as Fidson Healthcare, Emzor Pharmaceutical and Afrigen Biologics.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 13 March 2023
Updated by: Riya Doshi

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up